Merck & Co top-selling drugs revenue 2023 - Statista
May 21, 2024 · Keytruda is not only Merck & Co.’s top product but also one of the best-selling drugs worldwide, generating some 25 billion U.S. dollars in revenue during 2023. The cancer drug with the generic...
Products list - Merck.com
Products list. The product websites presented here are intended for use in the United States, its territories and Puerto Rico only. Other countries may have different regulatory requirements and review practices that may require referencing different information.
With $25B in sales, Merc's Keytruda, set to be top-selling drug
Feb 1, 2024 · With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world’s top-selling drug in 2023.
Merck & Co. - Statistics & Facts | Statista
Feb 29, 2024 · Merck & Co.'s top-selling drugs 2023. Top selling products of Merck & Co. based on revenue in 2023 (in million U.S. dollars)
Merck Announces Fourth-Quarter and Full-Year 2023 Financial …
Feb 1, 2024 · The following table reflects sales of the company’s top pharmaceutical products, as well as sales of Animal Health products. Full-year 2023 pharmaceutical sales grew 3% to $53.6 billion.
Merck Announces Fourth-Quarter and Full-Year 2021 Financial …
Feb 3, 2022 · The following table reflects sales of the company’s top pharmaceutical products, as well as sales of Animal Health products.
Products Section - Merck
EXPLORE PRODUCT OFFERINGS. Merck is a vibrant team of specialists in Healthcare, Life Science and Electronics. We share a love of science and a passion for technology. Explore our products across our businesses sectors.
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
May 28, 2024 · Merck’s oncology king Keytruda rose to the top last year, adding yet another feather in its cap. With more than 30 indications across various cancer types and stages, the PD-L1 inhibitor shows...
Top 10 drugs from new Merck, new Pfizer - Fierce Pharma
Feb 17, 2010 · Here's Pfizer's list to start: Lipitor, cholesterol drug, $3.175 billion, a 1 percent increase over the same period last year; Lyrica, for fibromyalgia and nerve pain, $820 million, a 17 percent ...
Merck Receives Another Boost for Its Top-Selling Drug
Nov 4, 2021 · Merck's best-selling drug is already approved in Europe, the U.S., and elsewhere for a wide variety of indications, including melanoma, lung cancer, head and neck cancer, and Hodgkin's...
- Some results have been removed